1.
M. Mokhtari, M. Sadeghi, A. Talebi. "MONOCLONAL ANTIBODY HBME-1 USEFULNESS IN DIFFERENTIATION OF BENIGN NEOPLASM AND DIFFERENTIATED THYROID CARCINOMA". Acta Med Iran. 1;43(2):85-88.